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Abstract
Background: Antibiotic use in human and veterinary medicine is considered a main driver of antimicrobial
resistance. Although guidelines to promote appropriate use of antimicrobials in veterinary patients have been
developed, antibiotic overprescription is assumed to be a common problem. The goal of this study was to
investigate antimicrobial use in cats in Switzerland with acute upper respiratory tract disease (aURTD), feline lower
urinary tract disease (FLUTD) and abscesses, and to assess compliance of prescription with consensus guidelines. A
total of 776 cases (aURTD, n = 227; FLUTD, n = 333; abscesses, n = 216) presented to two university hospitals and 14
private veterinary practices in Switzerland during 2016 were retrospectively evaluated. Clinical history, diagnostic
work-up and antimicrobial prescription (class, dosage, duration) were assessed.
Results: A total of 77% (aURTD), 60% (FLUTD) and 96% (abscesses) of the cases received antibiotic therapy; 13–24%
received combination or serial therapy. The cats were treated for a median of 7 (abscesses) and 10 days (aURTD, FLUTD).
Treatments with potentiated aminopenicillins (40–64%), third generation cephalosporins (25–28%), aminopenicillins (12–
24%) and fluoroquinolones (3–13%) were most common. Prescriptions were judged in complete accordance with
consensus guidelines in 22% (aURTD), 24% (FLUTD) and 17% (abscesses) of the cases. Antibiotics were prescribed although
not indicated in 34% (aURTD), 14% (FLUTD) and 29% (abscesses) of the cases. The presence of lethargy, anorexia or fever in
cats with aURTD, and the detection of bacteriuria in cats with FLUTD were significantly associated with antibiotic therapy.
Although diagnostic work-up was significantly more common (aURTD: university hospitals, 58%; private practices, 1%; FLUTD:
university hospitals, 92%; private practices, 27%) and the use of critically important antibiotics significantly less common at
the university hospitals (aURTD, 10%; FLUTD, 14%) compared to private practices (aURTD, 38%; FLUTD, 54%), the frequency
of antibiotic treatment was not different between the university hospitals and private practices.
Conclusions: Our results indicate that overprescription of antibiotics in cats in Switzerland is common and accordance with
guidelines is poor. The study highlights the need to promote antimicrobial stewardship in small animal medicine.
Keywords: Antibiotic prescription, Antimicrobial stewardship, Resistance, Guidelines, Acute upper respiratory tract disease,
Feline lower urinary tract disease, FLUTD, Abscess, Infection
Background
Mitigation of antimicrobial resistance has been an emer-
ging topic that plays an important role in human and vet-
erinary medicine. Antimicrobial resistance in bacteria is a
naturally occurring phenomenon and has been subject to
evolution over millions of years [1–5]. The frequent use of
antimicrobials in human and veterinary medicine and in
agriculture exerts an enormous selection pressure on bacter-
ial populations and promotes the development of
multidrug-resistant bacteria that can readily spread their re-
sistance genes by various mechanisms [1–3]. Antibiotic use
in veterinary medicine is discussed as one of the main drivers
for resistance development. In Europe, around 8000 tons of
antibiotics were sold for veterinary use in 2015, with pro-
nounced differences between countries [6]. The amount of
antibiotics used in companion animals in Europe in com-
parison to the amount prescribed in livestock is relatively
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small [6], but is not to be neglected. The close contact of
pets with their owners facilitates the transmission of
multidrug-resistant organisms between humans and com-
panion animals [1, 7–14]. Furthermore, the trend for inten-
sive medical care of dogs and cats poses a risk for
nosocomial infections [15–18] and is associated with an in-
creasing number of geriatric and immunosuppressed pa-
tients that are highly susceptible to infections with
multidrug-resistant bacteria.
Based on recent data, Centres for Disease Control and
Prevention estimates that approximately 30 ̶ 50% of anti-
biotic prescriptions in humans are unnecessary [19, 20].
Surveys describing antimicrobial use in dogs and cats re-
vealed that antibiotics are frequently prescribed, in particu-
lar beta-lactam antibiotics [21–30], and that cats are
especially exposed to the critically important third gener-
ation cephalosporins [21–25, 30–33]. Most previous studies
performed in dogs and cats were based on questionnaires
presenting hypothetical scenarios that have been sent out
to veterinarians [22, 23, 28, 33–37]. These studies are com-
monly hampered by a selection bias, recall bias and prevari-
cation bias, and the answers given do not necessarily reflect
the actual prescribing practice. Some studies analyzed phar-
macy records [38, 39] and veterinary or pet insurance data-
bases [21, 22, 24–27, 29, 30, 32] but only few studies
evaluated whether prescriptions practice was in accordance
with relevant guidelines [24, 26, 27, 33, 34].
The aims of this study were to investigate the antimicro-
bial prescribing practice in Switzerland for indications in
cats with frequent use of antibiotics, i.e., in cases of acute
upper respiratory tract disease (aURTD), feline lower urin-
ary tract disease (FLUTD) as well as abscesses, and to
evaluate to what extend the prescriptions comply with re-
cently established consensus guidelines [40, 41]. The a
priori compliance with the proposed guidelines was evalu-
ated in this study to lay the basis to monitor, in a next
step, the impact of these guidelines on antimicrobial pre-
scription patterns in Switzerland.
Results
Case characteristics
A total of 776 cats were included in the study. Case charac-
teristics are shown in Table 1. A detailed overview of clinical
symptoms, diagnostic procedures and antimicrobial prescrip-
tion for each indication is given in Tables 2, 3 and 4. Cats
with aURTD were significantly younger (median age: 3 years)
than cats with FLUTD (median age: 8 years, p < 0.001) or
cats with abscesses (median age: 7 years; p < 0.001) and more
likely to be intact (aURTD and FLUTD: p < 0.001, aURTD
and abscesses: p < 0.001). Furthermore, the cats presented to
the university hospitals were more often pretreated with anti-
biotics (aURTD, 30%; FLUTD, 18%) and hospitalized
(aURTD, 72%; FLUTD, 69%) when compared with the cases
in private practices (pretreatment: aURTD, 4%; FLUTD, 2%;
hospitalization: aURTD, 3%; FLUTD, 15%). The frequency of
antibiotic prescription differed between the indications (per-
centage of cases treated: aURTD, 77%; FLUTD, 60%; ab-
scesses, 96%; p < 0.001), but was not significantly associated
with breed, age or sex of the cats.
Antibiotic prescription for aURTD
Of 227 cats with aURTD, 175 (77%) received antibiotic ther-
apy with the following substance classes: potentiated amino-
penicillins (40%), third generation cephalosporins (28%),
aminopenicillins (24%), tetracyclines (16%), fluoroquinolones
(4%), amphenicols (2%), macrolides (2%), first generation
cephalosporins and penicillins (1% each); 15% of the cases
received combination or serial therapy. The antimicrobial
combinations used were potentiated or non-potentiated ami-
nopenicillins together with fluoroquinolones, first generation
cephalosporins, tetracyclines, amphenicols or third gener-
ation cephalosporins. One cat received a triple therapy con-
sisting of an aminopenicillin, a fluoroquinolone and a
tetracycline. The cats were treated for 4 to 37 days (median
of 10 days). Antibiotic therapy was significantly associated
with the indications listed in the guidelines (presence of leth-
argy, anorexia or fever, p= 0.002). The treatment decision
was judged as being compliant with the guidelines (justifica-
tion score-1, JS-1) in 49 cases (22%) and not in accordance
with the guidelines in 135 cases (59%; JS-2: n= 4, 2%; JS-3: n
= 48, 21%; JS-4, n= 83, 36%). In the 83 cases where a
complete discrepancy with the guidelines was found (JS-4),
antibiotic prescription although not indicated (overprescrip-
tion) occurred in 78 cases (94%) whereas 5 cases (6%) did
not receive antibiotics despite indicated in the guidelines.
The lack of information on the presence or absence of dis-
ease symptoms as listed in the guidelines precluded judg-
ment in 43 cases (19%). Judgement of antimicrobial
prescription was significantly more often not possible in pri-
vate practices compared to the university hospitals (p =
0.001).
The diagnostic work-up and antimicrobial prescription
patterns differed between private practices and univer-
sity hospitals (Table 2). The aURTD cases were signifi-
cantly more frequently tested by PCR for the presence of
respiratory pathogens at the university hospitals (58%)
compared to private practices (1%). The choice of anti-
biotic was significantly more often in disagreement with
the guidelines (JS-3) at the university hospitals (61%)
than at the private practices (12%). This was mainly due
to the more common use of potentiated aminopenicillins
(university hospitals, 90%; private practices, 29%) and
the less common use of aminopenicillins (university hos-
pitals, 3%; private practices, 28%) at the university hospi-
tals compared to private practices. On the other hand,
the use of critically important antibiotics was signifi-
cantly more common in private practices (38%; univer-
sity hospitals, 10%). The decision to use antibiotics for
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Table 1 Characteristics of cats with aURTDa, FLUTDb, and abscesses presented to university hospitals or private practices
Parameter aURTDª FLUTDb Abscesses
University hospitals Private practices p-value University hospitals Private practices p-value Private practices
Total number of cases n = 43 n = 184 n = 130 n = 203 n = 216
Sex Female 17 (40%) 82 (45%) n.s.c 43 (33%) 97 (48%) 0.006 64 (30%)
Male 24 (55%) 97 (53%) 87 (67%) 104 (51%) 148 (68%)
Unknown 2 (5%) 5 (1%) n.a.d 0 (0%) 2 (1%) n.a.d 4 (2%)
Age (years) Median (range; CIe) 5 (0.042 1̶6; 2, 9) 2 (0.06–19; 1, 4) n.s.c 7, (1–21; 7, 9) 8 (0.17–20; 6, 9) n.s.c 7 (1–18; 6, 8)
Breed Purebred 11 (26%) 33 (18%) n.s.c 36 (28%) 33 (16%) 0.026 14 (6%)
Mixed breed 29 (67%) 143 (78%) 90 (69%) 157 (77%) 190 (88%)
Unknown 3 (7%) 8 (4%) n.a.d 4 (3%) 13 (7%) n.a.d 12 (6%)
Vaccinated Yes 14 (33%) 28 (15%) n.s.c n.a.d n.a.d n.a.d n.a.d
No 17 (39%) 50 (27%) n.a.d n.a.d n.a.d
Unknown 12 (28%) 106 (58%) n.a.d n.a.d n.a.d n.a.d n.a.d
ªaURTD, acute upper respiratory tract disease; bFLUTD, feline lower urinary tract disease; cn.s., not significant; dn.a., not applicable; eCI, confidence interval
Table 2 Diagnostic work-up and antibiotic prescription in aURTDa cases presented to university hospitals or private practices
Parameter University hospitals Private practices p-value
Total number of cases n = 43 n = 184
Diagnostic work-up with PCRb Yesc 25 (58%) 2 (1%) <0.001
At least one of the symptoms listed in the guidelinesd Yesc 29 (68%) 37 (21%) <0.001
Unknown 1 (3%) 42 (23%)
Hospitalization Yesc 31 (72%) 5 (3%) <0.001
Pre-treated with antibiotics Yesc 13 (30%) 8 (4%) <0.001
Unknown 2 (5%) 4 (2%)
Antibiotic therapy Yesc 31 (72%) 144 (78%) n.s.e
Antibiotic classes Potentiated aminopenicillins 28 (90%) 42 (29%) <0.001
Third generation cephalosporins 2 (6%) 47 (33%) 0.002
Aminopenicillins 1 (3%) 40 (28%) 0.002
Tetracyclines 2 (6%) 26 (18%) n.s.e
Fluoroquinolones 1 (3%) 6 (4%) n.s.e
Amphenicols 0 (0%) 3 (2%) n.s.e
Macrolides 0 (0%) 3 (2%) n.s.e
First generation cephalosporins 0 (0%) 1 (1%) n.s.e
Penicillins 0 (0%) 1 (1%) n.s.e
Combination or serial therapyf Yesc 4 (13%) 21 (15%) n.s.e
Critically important antibioticf Yesc 3 (10%) 55 (38%) 0.001
Duration of therapy (days) Median (range) 12 (4–27) 10 (4–37) n.s.e
Justification scoref 1 12 (28%) 37 (20%) n.s.e
2 1 (2%) 3 (2%) n.s.e
3 26 (61%) 22 (12%) <0.001
4 3 (7%) 80 (43%) <0.001
Judgement not possible 1 (2%) 42 (23%) 0.001
aaURTD, acute upper respiratory tract disease; bPCR, polymerase chain reaction; cValues for the category “no” (reference group) are not shown; dPoor general
condition, fever, lethargy and/ or anorexia; en.s., not significant; fAs defined in methods
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treatment was significantly more often in disagreement
with the guidelines (JS-4) in the private practices (43%)
when compared to the university hospitals (7%).
Antibiotic prescription for FLUTD
Of 333 cats with FLUTD, 200 cases (60%; 56 with bacterial
cystitis, 144 with other/unknown diagnosis) received anti-
biotic therapy with the following substance classes: potenti-
ated aminopenicillins (61%), third generation cephalosporins
(26%), fluoroquinolones (13%), aminopenicillins (12%), first
generation cephalosporins (3%), amphenicols (1%) and tetra-
cyclines (1%); 13% received combination or serial therapy.
For combination therapy, potentiated or non-potentiated
aminopenicillins together with fluoroquinolones or third
generation cephalosporins were used. The cats were treated
for 1 to 56 days (median of 10 days). The presence of bacteri-
uria was significantly associated with antibiotic therapy (p <
0.001). The treatment decision was judged as being compli-
ant with the guidelines (JS-1) in 81 (24%) and not in accord-
ance with the guidelines in 82 (25%) cases (JS-2: n= 1, 1%;
JS-3: n= 31, 9%; JS-4: n= 50, 15%). In the 50 cases with
complete discrepancy to the guidelines (JS-4), antibiotics
were prescribed although not indicated (overprescription) in
47 cases (94%) and cats were not treated with antibiotics des-
pite indicated in the guidelines in 3 cases (6%). Inadequate
diagnostic work-up (154 out of 170 cases, 91%) was the main
reason to preclude judgment in 170 cases (51%).
Diagnostic work-up and antimicrobial prescription pat-
terns were again different between the university hospitals
and private practices (Table 3). Urine sediment analysis or
bacterial culture were significantly more commonly per-
formed at the university hospitals (92%) compared to private
practices (27%). When antimicrobial prescription at the uni-
versity hospitals was compared to the private practices, pre-
scription was significantly more often graded as JS-1
(complete agreement with the guidelines; university hospi-
tals, 44%; private practices 12%), JS-3 (choice of antimicrobial
different from the guidelines; university hospitals, 17%; pri-
vate practices 4%) and JS-4 (complete discrepancy with the
guidelines; university hospitals, 30%; private practices 6%).
The use of critically important antibiotics was significantly
more common in private practices (54%) compared to the
Table 3 Diagnostic work-up and antibiotic prescription in FLUTDa cases presented to university hospitals or private practices
Parameter University hospitals Private practices p-value
Total number of cases n = 130 n = 203
Urine analysis performed Yesb 119 (92%) 55 (27%) <0.001
Sediment analysis Yesb 93 (72%) 50 (25%) <0.001
Bacterial culture Yesb 113 (87%) 20 (10%) <0.001
Confirmed bacterial etiologyc Yesb 45 (35%) 16 (8%) <0.001
Hospitalization Yesb 90 (69%) 30 (15%) <0.001
Pre-treated with antibiotics Yesb 23 (18%) 4 (2%) <0.001
Unknown 5 (4%) 3 (2%)
Antibiotic therapy Yesb 85 (65%) 115 (57%) n.s.d
Antibiotic classes Potentiated aminopenicillins 71 (84%) 50 (57%) <0.001
Third generation cephalosporins 7 (8%) 44 (38%) <0.001
Fluoroquinolones 5 (6%) 20 (17%) 0.017
Aminopenicillins 1 (1%) 22 (19%) <0.001
First generation cephalosporins 5 (6%) 1 (1%) n.s.d
Amphenicols 1 (1%) 0 (0%) n.s.d
Tetracyclines 1 (1%) 0 (0%) n.s.d
Combination or serial therapye Yesb 6 (7%) 20 (17%) n.s.d
Critically important antibiotice Yesb 12 (14%) 62 (54%) <0.001
Duration of therapy (days) Median (range) 13 (1 5̶6) 9 (1 4̶2) 0.012
Justification scoree 1 57 (44%) 24 (12%) <0.001
2 1 (1%) 0 (0%) n.s.d
3 22 (17%) 9 (4%) <0.001
4 39 (30%) 11 (6%) <0.001
Judgement not possible 11 (8%) 159 (78%) <0.001
aFLUTD, feline lower urinary tract disease; bValues for the category “no” (reference group) are not shown; cDefined as either positive urine sediment analysis or
positive bacterial culture; dn.s., not significant; eAs defined in methods
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university hospitals (14%). Furthermore, judgment of anti-
microbial prescription was significantly more often not pos-
sible in private practices (78%; university hospitals, 8%).
Antibiotic prescription for abscesses
Of 216 cats with abscesses, 207 cats (96%) received antibiotic
therapy with the following substance classes: potentiated
aminopenicillins (64%), third generation cephalosporins
(25%), aminopenicillins (24%), first generation cephalospo-
rins (6%), fluoroquinolones (3%), lincosamides (2%) and pen-
icillins (1%); 24% received combination or serial therapy.
Combination therapy was uncommon (3 cases) and anti-
microbial combinations used were potentiated or non-po-
tentiated aminopenicillins together with fluoroquinolones
or third generation cephalosporins. The cats were treated
for 1 to 24 (median 7) days. Local wound treatment was
carried out in 156 of 216 cases (72%) and drains were
placed in 33 of 216 cases (15%). Antibiotic therapy was not
associated with any of the symptoms listed in the guide-
lines, i.e., signs of generalization, poor general condition, se-
verely contaminated wounds, and/ or proximity to delicate
tissues. Antimicrobial therapy was judged in accordance
with the guidelines (JS-1) in 36 (17%) and not in
accordance with the guidelines in 95 (44%) cases (JS-2: n =
16, 7%; JS-3: n = 14, 7%; JS-4: n = 65, 30%). In the 65 cases
with complete discrepancy to the guidelines (JS-4), antibi-
otics were prescribed without indication (overprescription)
in 63 cases (97%) and cats were not treated with antibiotics
despite indicated in the guidelines in 2 cases (3%). Assess-
ment of prudent use was not possible for 85 cases (39%).
Discussion
The results of this study indicate that overprescription of
antibiotics in cats in Switzerland with aURTD, FLUTD
and abscesses is very common. When prescription was
compared to the consensus guidelines, 14–34% of all cases
received antibiotics although not indicated; when only the
cases were considered for which judgment of prudent use
was possible, the rate of antibiotic overprescription was
even higher (29–48%). The diagnostic work-up was more
elaborate at the university hospitals, and critically import-
ant antibiotics were less commonly prescribed at the uni-
versities, but the prudent use pattern of prescriptions was
not clearly superior when compared to private practices.
This was mainly due to the very common use of potenti-
ated aminopenicillins instead of non-potentiated
Table 4 Clinical signs, wound treatment and antibiotic prescription in cases with abscesses presented to private practices
Parameter Private practices
Total number of cases n = 216
At least one of the symptoms listed in the guidelinesa Yesb 65 (30%)
Unknown 85 (39%)
Local wound treatment Yesb 156 (72%)
Unknown 12 (6%)
Drain placement Yesb 33 (15%)
Antibiotic therapy Yesb 207 (96%)
Antibiotic classes Potentiated aminopenicillins 132 (64%)
Third generation cephalosporins 52 (25%)
Aminopenicillins 50 (24%)
First generation cephalosporins 12 (6%)
Fluoroquinolones 5 (3%)
Lincosamides 4 (2%)
Penicillins 1 (1%)
Combination or serial therapyc Yesb 48 (24%)
Critically important antibioticc Yesb 57 (28%)
Duration of therapy (days) 7 (1 2̶4)
Justification scorec 1 36 (17%)
2 16 (7%)
3 14 (7%)
4 65 (30%)
Judgement not possible 85 (39%)
aSigns of generalization, poor general condition, severely contaminated wounds, and/ or proximity to delicate tissues; bValues for the category “no”
(reference group) are not shown; cAs defined in methods
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aminopenicillins at the universities. On the other hand,
the quality of antimicrobial prescription could often not
be judged in the cases from private practices because the
diagnostic work-up or the symptoms of the patients were
not documented. The common discrepancy of antimicro-
bial prescription with recently established consensus guide-
lines [40, 41] at the two university hospitals is surprising
considering that senior clinicians of these hospitals were in-
volved in the drafting of the guidelines. The overall fre-
quency of antimicrobial treatment was also not different at
the university hospitals compared to private practices.
However, our data indicates that the animals presented to
the university hospitals were more often pretreated or hos-
pitalized, and could thus have been in a more debilitated
condition.
Only 17 ̶ 24% of the treatment decisions in this study
were classified as JS-1 and therefore in complete accord-
ance with the consensus guidelines. Recent studies in dogs
and cats have reported an overall agreement of 0–69%
with published guidelines [24, 27, 33, 34]. This overall low
accordance raises the question of whether the proposed
guidelines cannot be implemented in clinical practice, for
example, due to poor market availability of appropriate
antibiotic formulations, or whether the content is not well
disseminated among veterinary practitioners.
The critically important antibiotics used in cats in this
study were mostly third generation cephalosporins as well as
fluoroquinolones. Third generation cephalosporins were the
second most frequently prescribed antibiotic class and were
used in 25–28% of the cases. This mirrors the results ob-
tained in previous studies [21–25, 31–33] and could likely be
explained by the convenient application (as a single subcuta-
neous injection) and the long dosing interval (2 weeks) of
the authorized product in Switzerland (cefovecin, Convenia®,
Zoetis, Delémont, Switzerland). A previous study evaluating
electronic health records found that inability to orally medi-
cate the cat was the most common reason given for prescrib-
ing cefovecin [42]. An online survey in veterinarians in
Switzerland also revealed that the route of application was
the most important factor in the choice of antimicrobial
therapy in cats [43]. In our study, the prescription of critically
important antibiotics was significantly more frequent in pri-
vate practices compared to the university hospitals. This ob-
servation supports the hypothesis that the workplace
environment is an important factor determining treatment
decisions and antimicrobial use [44]. University hospitals, as
training centers, may have stronger restrictions for the use of
critically important antibiotics: one of the two university hos-
pitals of this study completely forbids the use of third gener-
ation cephalosporins in its patients. On the other hand, the
cats at the university hospitals were more commonly hospi-
talized compared to the cases in private practices, thus allow-
ing for parenteral medication and avoiding the problem of
oral application of the antibiotic drug.
Antimicrobial prescription in the absence of proper diag-
nostic work-up was very common in this study. In only 40%
of the FLUTD cases overall, and in only 10% of the FLUTD
cases in private practices, bacterial culture and susceptibility
testing were carried out. In a previous study based on a
questionnaire, 32.5% of companion animal practitioners in
Europe reported that they frequently undertake antimicrobial
susceptibility testing whereas 9.1% never demand such tests
[45]. In another survey from Italy, 91% of the practitioners
reported to carry out microbiological analysis, although only
20% reported to do so frequently [35]. Our results indicate
that these data based on questionnaires are probably too op-
timistic and that bacterial culture, an essential diagnostic
work-up step for cats with FLUTD, is rarely performed in
private practices. In contrast, bacterial culture was performed
in 87% of the FLUTD cases presented to the university hos-
pitals, although this did not result in a less frequent prescrip-
tion of antimicrobials. Interestingly, 56% of the FLUTD cases
at the universities received antibiotic therapy despite the ab-
sence of bacteria in urine culture. A total of 20% of these cats
were pretreated with antibiotics which could have affected
the interpretation of a negative bacterial culture result. Also
many of these cats suffered from urinary tract obstruction
and antibiotic therapy was initiated after removal of the in-
dwelling urinary catheter.
The trend towards more diagnostic testing at the uni-
versity hospitals is also demonstrated by a more frequent
use of PCR for the detection of feline calicivirus (FCV)
and feline herpesvirus-1 (FHV) in cases with aURTD.
These tests can be useful to support a diagnosis of viral
infection and to initiate supportive measures such as the
prescription of famciclovir in the case of FHV infection,
and thus reduce the use of antibiotics [46]. In this study,
the detection of FCV and FHV did not affect the fre-
quency of antibiotic prescription. Overprescription of
antibiotics in cats with aURTD was common: although
only 29% of the cats showed symptoms that would have
justified an antibiotic therapy according to the consensus
guidelines, 77% of the cases received antibiotic treat-
ment. Potentiated aminopenicillins were most often pre-
scribed at the university hospitals, while third generation
cephalosporins and aminopenicillins were most com-
monly used in private practices. A study revealed that
amoxicillin with clavulanic acid is not superior to doxy-
cycline when treating cats with signs of acute respiratory
tract disease [47]. Our data, however, indicate that the
cases presented to the university hospitals were in a
more debilitated condition, because 72% of the cats with
aURTD were hospitalized in comparison to 3% in private
practices. Furthermore, 68% of the cats presented to uni-
versity hospitals had symptoms listed in the guidelines,
while at the private practices only 21% of the cats were
reported to show a poor general condition, fever, leth-
argy and/or anorexia. The more compromised clinical
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condition of the patients at university hospitals could ex-
plain the common use of potentiated aminopenicillins
instead of doxycycline due to the lack of a licensed in-
jectable doxycycline preparation in Switzerland. However,
potentiated instead of non-potentiated aminopenicillins were
almost exclusively used at the universities. Non-potentiated
and potentiated aminopenicillins are often used interchange-
ably although it has been shown that the use of clavulanic
acid may increase AmpC-mediated resistance causing indu-
cible organisms to become insensitive to 1st to 3rd gener-
ation cephalosporins [48, 49]. The frequent use of
potentiated aminopenicillins instead of non-potentiated ami-
nopenicillins in this study could also be due to the better
availability of these products on the market, since they make
up the largest part of antimicrobial compounds licensed for
cats in Switzerland [50].
A total of 96% of the cats with abscesses received anti-
biotic treatment but only 30% of the cats presented symp-
toms that, according to the guidelines, would justify an
antibiotic therapy. Our findings are in line with results
from previous studies where frequency of antibiotic pre-
scriptions for skin diseases such as wounds or abscesses
ranged from 90 to 97% [24, 32]. In children, antibiotics
might sometimes be applied instead of local wound drain-
age to avoid anesthesia or sedation [51]. However, 72% of
the cats in this study received local wound treatment and
passive drains were placed in 15% of the cats. It can be as-
sumed that, in many of these cases, antibiotics were sup-
plemented as a preventative measure. Studies from
human medicine showed that appropriate drainage of the
abscess is important and that antibiotic treatment may not
be necessary [52–55]. Several guidelines for small animals
state that an antibiotic treatment is not indicated if the ab-
scess is well-defined and the animal is in a good general
condition [56–58].
The present study has some limitations. The insuffi-
cient documentation in the databases limited the in-
formation available for review. The presence of
bacteria in urine sediment analysis of an aseptically
collected urine sample was considered appropriate to
confirm a bacterial etiology in cases with FLUTD, al-
though this is considered insufficient diagnostic
work-up according to some guidelines due to the vari-
able quality of interpretation, the risk of stain contam-
ination as well as the possibility of false positive
results [57, 59]. In a recent study, overall accuracy of
in-house microscopic evaluation for bacteriuria in primary
practice was only 64.5% when comparing results to reference
bacterial cultures [60]. We decided to consider these results
since former studies have reported accuracies of urine sedi-
ment analysis of 97–98% when performed by experienced la-
boratory personal [61–64]. Furthermore, the generally low
prevalence of bacterial cystitis in cats should not result in
many false positive results [65–67].
The assessment score used in this study leaves a mar-
gin of interpretation and the justification of antimicro-
bial prescription was based on consensus guidelines
released in Switzerland. Results could differ to some ex-
tent when comparing prescription to guidelines from
other countries. Furthermore, the limited number of
cases included per practice did also not allow for a stat-
istical analysis at a single practice level. Also, there could
be a selection bias since the participation in this study
was on a voluntary basis and the enrolled practices
might have been more aware of antimicrobial resistance
and more likely to prescribe antibiotics prudently.
Conclusions
The present study highlights the need to promote anti-
microbial stewardship in small animal medicine and to
implement effective intervention strategies. Particular at-
tention should be paid to the education of veterinarians,
the propagation of diagnostic work-up and the need for
proper documentation to justify antibiotic treatment.
Antimicrobial stewardship at universities should be ur-
gently advanced as they serve as role models for veterin-
ary practice. Developments on the market to provide
small spectrum antibiotics for convenient application
would be of particular importance in cats since the route
of application is a major factor in the choice of antimi-
crobials in this species. Such new products will contrib-
ute to ensure that effective antimicrobials remain
available in the future to combat bacterial infections in
human and veterinary medicine.
Methods
Cases presented between January 1st and December
31st 2016 to the two Swiss university teaching hospi-
tals for small animals (Vetsuisse Faculty Bern and
Zurich) as well as to fourteen private veterinary prac-
tices across Switzerland were included. The private
practices participated on a voluntary basis following a
nationwide call. In order to identify patients matching
the inclusion criteria (Table 5), the electronic records
were scanned for predetermined search terms (Table
5) using search functions provided by the particular
software. For practical reasons, only private practices
using either OblonData® (Amacker&Partner Informatik
AG, Zurich, Switzerland) or Diana SUISSE® (Diana
Software AG, Zurich, Switzerland) were enrolled. A
full text search was conducted and the matches were
manually reviewed. All cases from the two university
hospitals matching the criteria were included. From
each private practice, 16 cases per indication that
matched the criteria were randomly selected via the
sampling function of Microsoft® Excel. In the eight
private practices where less than 16 cases per indica-
tion were found, all cases were included. The number
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of cases was balanced by limiting the number to 16
per practice to avoid overrepresentation of larger pri-
vate practices. Although not all cases were included,
the random selection should ensure that the results
remain representative.
Signalment, vaccination status, clinical history, reports
on clinical examination, antibiotic pretreatment, diag-
nostic work-up, comorbidities, hospitalization and anti-
microbial therapy (substance class, dose, frequency of
application and duration of therapy) were retrieved from
the medical records. The evaluated diagnostic work-up
for aURTD included PCR for FCV and FHV; for FLUTD,
urine sediment analysis and urine bacterial culture were
assessed. Bacteriuria was defined as the presence of
bacteria in the urine sediment analysis or in the bacterial
culture from an aseptically collected urine sample
(cystocentesis or catheterization). Complicated urinary
tract infections were defined as infections that were
caused by anatomical or functional changes or a comor-
bidity, that predispose the patient to persistent or recur-
rent infections or treatment failure [68]. Critically
important antibiotics comprised third or higher gener-
ation cephalosporins, quinolones, macrolides, ketolides,
glycopeptides and polymyxins [69]. Combination therapy
was defined as the prescription of two or more antibiotic
classes at the same time; serial therapy as the prescrip-
tion of one antibiotic class followed by a different anti-
biotic class. Antimicrobial prescription was compared
with the consensus guidelines summarized in Table 6
using a previously published JS with modifications
shown in Table 7 [70]. The guidelines were published
in December 2016 [40] and can be accessed online as
the AntibioticScout tool [71]. The present study eval-
uated antimicrobial prescription prior to the imple-
mentation of the guidelines to use this data as a
baseline for follow-up studies on the influence of the
guidelines on antimicrobial prescription in
Switzerland.
For statistical analysis, the commercially available
SPSS® software (SPSS Inc., IL, USA) was used.
Descriptive statistics and comparisons of groups were
conducted. Because the continuous variables were not
Table 5 Inclusion and exclusion criteria and search terms for aURTDa, FLUTDb and abscesses
Indication Inclusion criteria Exclusion criteria Search terms
aURTDª Nasal discharge with infectious or unknown
etiology lasting no longer than 2 weeks
Evidence of fungal infection,
neoplasia or involvement of
the lower respiratory tract
Upper respiratory tract infection, rhinotracheitis, rhinitis,
sinusitis, nasal discharge, sneezing, coughing, stridor,
dyspnea, tachypnea, cat flu, herpes, calici, mycoplasma,
chlamydia, laryngitis
FLUTDb Stranguria, pollakiuria, periuria, pigmenturia
or dysuria and a diagnosis of bacterial cystitis,
bladderstones, urethrastones, urethral plugs,
idiopathic cystitis or cystitis of unknown origin
Involvement of the upper
urinary tract
Lower urinary tract disease, FLUTDb, pollakiuria,
polyuria, anuria, stranguria, dysuria, hematuria, bloody
urine, urinary stones, bladder stones, urolithiasis,
concrements, cystitis, urethra obstruction, urinary tract
infection, UTI, urinary incontinence
Abscess Bite abscesses or abscesses of unknown origin Anal gland abscesses, tooth
root abscesses, foreign body
abscesses
Abscess, bite wound, bite, pus
ªaURTD, acute upper respiratory tract disease; bFLUTD, feline lower urinary tract disease
Table 6 Consensus guidelines [40, 41] used to evaluate prudent use of antimicrobials
Indication Comment Antibiotic Dosage
(mg/kg)
Application
frequency
Treatment duration
(days)
aURTDa Antibiotic therapy is only indicated if poor general condition,
fever, lethargy and/or anorexia are present
Doxycycline 10 / 5 SIDb/BIDc 5–14
Amoxicillin 15–20 BIDc/TIDd 5–14
FLUTDe Complicated UTIf are defined as infections that are caused by
anatomical or functional changes or disorders of the immune
system
Uncomplicated
UTIf:
Amoxicillin 11–15 BIDc/TIDd 5–7
Complicated UTIf:
Amoxicillin/Clavulanic acid 12.5–20 BIDc/TIDd 5–28
Abscess Antibiotic therapy is only indicated if signs of generalization,
poor general condition, severely contaminated wounds, and/
or proximity to delicate tissues (e.g., joints) are present
Amoxicillin 15–20 BIDc 5–7
Amoxicillin/Clavulanic acid 12.5–20 BIDc 5–7
Cefalexin 20–30 BIDc/TIDd 5–7
Clindamycin 10–15 BIDc 5–7
Cefazolin 20 BIDc 5–7
aaURTD, acute upper respiratory tract disease; bSID, once daily; cBID, twice daily; dTID, three times daily; eFLUTD, feline lower urinary tract disease; fUTI, urinary
tract infection
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normally distributed, the Mann Whitney U Test was
used to compare the median age as well as the dur-
ation of therapy between the university hospitals and
private practices. For the median age, 95% confidence
intervals (CI) were calculated. The Chi square test
was performed for comparison of categorical variables
(case characteristics, diagnostic work-up,
hospitalization, antibiotic pretreatment and antibiotic
prescription) between university hospitals and private
practices; frequency of antibiotic therapy between the
indications; association of symptoms listed in the
guidelines (for aURTD and abscesses) or the presence
of bacteriuria (for FLUTD) with antibiotic therapy.
The level of significance was set at p < 0.05. For the
comparison of the justification scores between univer-
sity hospitals and private practices the Chi square test
was performed and the significance level was adapted
for multiple tests using the Bonferroni correction.
Abbreviations
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